Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Koziel

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Viral Hepatitis|July 2, 2013
Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis CK Yanagisawa, S Yue, H J van der Vliet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Kenneth E Sherman, Janet W Andersen, Adeel A Butt, et al.
The American Journal of Gastroenterology|February 25, 2010
Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infectionDavid Nunes, Catherine Fleming, Gwynneth Offner, et al.
Journal of Viral Hepatitis|May 11, 2012
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis CC Morishima, A M Di Bisceglie, A L Rothman, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Gastroenterology|March 15, 2006
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic responseSanaa M Kamal, Amr E Fouly, Refaat R Kamel, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
The New England Journal of Medicine|July 30, 2004
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected personsRaymond T Chung, Janet Andersen, Paul Volberding, et al.
Ejhaem|February 26, 2024
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell diseaseMyrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, et al.
Journal of Clinical and Translational Science|October 30, 2019
Enhancing Clinical Research Professionals' Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinatorsThomas P Shanley, Nancy A Calvin-Naylor, Ruthvick Divecha, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Viral Hepatitis|July 2, 2013
Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis CK Yanagisawa, S Yue, H J van der Vliet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2010
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Kenneth E Sherman, Janet W Andersen, Adeel A Butt, et al.
The American Journal of Gastroenterology|February 25, 2010
Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infectionDavid Nunes, Catherine Fleming, Gwynneth Offner, et al.
Journal of Viral Hepatitis|May 11, 2012
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis CC Morishima, A M Di Bisceglie, A L Rothman, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Gastroenterology|March 15, 2006
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic responseSanaa M Kamal, Amr E Fouly, Refaat R Kamel, et al.
Vaccine|July 6, 2010
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220E T Overton, M Kang, M G Peters, et al.
The New England Journal of Medicine|July 30, 2004
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected personsRaymond T Chung, Janet Andersen, Paul Volberding, et al.
Ejhaem|February 26, 2024
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell diseaseMyrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, et al.
Journal of Clinical and Translational Science|October 30, 2019
Enhancing Clinical Research Professionals' Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinatorsThomas P Shanley, Nancy A Calvin-Naylor, Ruthvick Divecha, et al.
Pageof 6